This proposal describes plans to develop a user-friendly interactive statistical software package to perform dose response modeling and quantitative risk assessment. Cancer and non-cancer applications in a variety of standard and non-standard contexts will be covered. Phase I focuses on software to fit multivariate dose response models to developmental toxicity data. Specifically, the approach involves a three- stage model that accounts for exposure effects on fetal death, malformation and weight. The software will provide for: (l) the fitting of non-linear dose response models to clustered binary and continuous data; (2) graphical displays to facilitate assessment of model adequacy; and (3) estimation of Benchmark Doses (or, the doses corresponding to specific risk quantiles) based on multiple outcomes. These features will be accessible in an interactive, menu-based user-interface that facilitates data exploration and sensitivity analyses. Achievement of these Phase I goals will lead naturally to the long term goals (Phase II) of providing a cohesive and flexible package that accommodates risk assessment needs in virtually all contexts that are likely to be encountered in practice, including carcinogen bioassays, neurotoxicity testing.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA065019-01
Application #
2107780
Study Section
Special Emphasis Panel (ZRG7-SSS-1 (01))
Project Start
1994-08-04
Project End
1996-04-15
Budget Start
1994-08-04
Budget End
1996-04-15
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Cytel Software Corporation
Department
Type
DUNS #
183012277
City
Cambridge
State
MA
Country
United States
Zip Code
02139